Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

15.25 -0.18 (-1.17%)
Streaming Delayed Price Updated: 9:34 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Earnings Scheduled For January 6, 2022
Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $16.90 million.... 
Via Benzinga
Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Axie Infinity Crypto Yield Games
We Pay - You Play - You Earn 
Via IssueWire
Analyzing Simulations Plus's Ex-Dividend Date
On July 12, 2021, Simulations Plus (NASDAQ:SLP) declared a... 
Via Benzinga
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Names Sharlene Evans to Board of Directors
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases GastroPlus® Version 9.8.2
From Simulations Plus, Inc.
Via Business Wire
60 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride... 
Via Benzinga
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus, inc (SLP) Q4 2021 Earnings Call Transcript
SLP earnings call for the period ending August 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shar... 
Via Benzinga
Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Scheduled For October 25, 2021
Companies Reporting Before The Bell • HNI (NYSE:HNI) is expected to report quarterly earnings at $0.43 per share on revenue of $592.14 million. • Travelzoo (... 
Via Benzinga
Simulations Plus Announces the University+ Program
From Simulations Plus, Inc.
Via Business Wire
Bet On Biopharma: Data, Digitization, Discovery
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the... 
Via Talk Markets
Simulations Plus Announces Cash Dividend
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
Simulations Plus Releases ADMET Predictor® (X.3)
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Receives New Grant Award From the FDA
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
From Simulations Plus, Inc.
Via Business Wire
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
From Simulations Plus, Inc.
Via Business Wire
Return on Capital Employed Overview: Simulations Plus
Pulled from Benzinga Pro data Simulations Plus (NASDAQ:SLP) posted Q3 earnings of $4.42 million, an increase from Q2 of 31.42%. Sales dropped to $12.78 million, a 2.81% decrease... 
Via Benzinga
Looking into Simulations Plus's Return on Capital Employed
Pulled from Benzinga Pro data Simulations Plus (NASDAQ:SLP) posted Q3 earnings of $4.42 million, an increase from Q2 of 31.42%. Sales dropped to $12.78 million, a 2.81% decrease... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.